CELACTONE

This brand name is authorized in Nigeria.

Active ingredients

The drug CELACTONE contains one active pharmaceutical ingredient (API):

1	Spironolactone UNII 27O7W4T232 - SPIRONOLACTONE
	Spironolactone, as a competitive aldosterone antagonist, increases sodium excretion whilst reducing potassium loss at the distal renal tubule. It has a gradual and prolonged action.
	Read more about Spironolactone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0435	Tablet	CELACTONE 100 TABLET TAB 100 mg 1 X 28	CELACTONE 100 TABLET CELACTONE SPIRONOLACTONE BP 100MG POM TABLETS 1 X 28 DIURETIC CHEZ RESOURCES PHARM LTD 7, CALABAR STREET FEGGE, ONITSHA ANAMBRA STATE ALPA LABORATORIES PVT LTD 32/2 A. B ROAD PIGDAMBER-453446, INDORE (M.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 30/09/2019 R R R C4-0435	30/01/2020
C4-0437	Tablet	CELACTONE 50 TABLET TAB 50 mg 1 X 28	CELACTONE 50 TABLET CELACTONE SPIRONOLACTONE BP 50MG POM TABLETS 1 X 28 DIURETIC CHEZ RESOURCES PHARM LTD 7, CALABAR STREET FEGGE, ONITSHA ANAMBRA STATE ALPA LABORATORIES PVT LTD 32/2 A. B ROAD PIGDAMBER-453446, INDORE (M.P), INDIA GMP- RBC LR- SATIS; FEES- PAID; NP: NA 30/09/2019 R R R C4-0437	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03DA01	Spironolactone	C Cardiovascular system → C03 Diuretics → C03D Potassium-sparing agents → C03DA Aldosterone antagonists
Discover more medicines within C03DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0435, C4-0437